Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB-001 for Recurrent Herpes Labialis
NCT01324466Phase 3Completed
- Sponsor
- BlueWillow Biologics
- Start
- Apr 2011
- Primary completion
- Jan 2012
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NB-001 in herpes labialis, sponsored by BlueWillow Biologics. Started Apr 2011; status: completed.
02
Drugs
NB-001
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT01324466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01324466.